Opiate Craving Reduction Study Using Post-detox Patients on Suboxone and Use of TEAS as Adjunctive Treatment

Withdrawn before enrolling · Not applicable

Conditions studied: Opioid-use Disorder

In brief

Pilot study of 12 outpatients in early recovery from illicit drug use,post-detox and on buprenorphine-naloxone maintenance will be offered 12 TEAS adjunct treatments over 6 weeks(X2/week) to ascertain if they experience any improvement in mood,sleep,overall quality of life and decrease drug cravings ultimately while facing everyday life stressors.

Key facts

Study ID

NCT02033746

Run by

Mclean Hospital

People needed

0

Starts

2015-08-01

Expected to finish

2017-12-01

Last updated by the study team

2018-02-22

Who can join

Age: 18 and older, up to 59. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-59 years old
• early recovery(0-3months of abstinence
• not currently detoxing
• maintained on buprenorphine-naloxone under the care of qualified MD
• proficient in the English language

You may not qualify if…

• having acute,psychiatric symptoms which would pose safety concerns,or an adherence to treatment barrier(active suicidality/psychosis/mania)
• severe cognitive disorders*not competent to give informed consent
• active cardiac disease or EKG abnormalities or with cardiac pacemaker
• currently detoxing from alcohol or illicit drugs
• inability or non-intention to attend all treatment sessions*history of seizures*pregnancy or breast feeding.

Where it is running

• McLean Hospital — Belmont, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.